HAEMONETICS CORP shareholders Q3 2023

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Jackson Creek Investment Advisors LLC 11,491$1,0290.44%
Olympiad Research LP 4,642$415,8300.41%
Hillsdale Investment Management Inc. 49,340$4,419,8770.40%
LGT CAPITAL PARTNERS LTD. 111,898$10,023,8230.36%
PEREGRINE CAPITAL MANAGEMENT LLC 128,407$11,502,6990.34%
WESTFIELD CAPITAL MANAGEMENT CO LP 559,963$50,161,4860.34%
RICE HALL JAMES & ASSOCIATES, LLC 57,833$5,180,6800.33%
Dean Capital Management 4,559$408,3950.31%
Neuberger Berman Group LLC 3,567,781$319,658,6660.29%
AMERICAN CAPITAL MANAGEMENT INC 80,995$7,255,5320.28%
ABLE Financial Group, LLC 5,645$505,6790.25%
First Personal Financial Services 10,498$940,4110.24%
ELEMENT CAPITAL MANAGEMENT LLC 30,545$2,736,2210.24%
CORNERCAP INVESTMENT COUNSEL INC 14,145$1,267,1090.23%
Cardinal Capital Management 11,188$1,002,2220.20%
DEAN INVESTMENT ASSOCIATES, LLC 11,391$1,020,4060.17%
ESSEX INVESTMENT MANAGEMENT CO LLC 11,208$1,004,0130.16%
Capital Research Global Investors 6,623,148$593,301,5980.16%
C M BIDWELL & ASSOCIATES LTD 2,389$214,0070.16%
GREAT LAKES ADVISORS, LLC 197,423$17,685,1520.16%
External links

This page lists HAEMONETICS CORP's shareholders in Q3 2023. To view HAEMONETICS CORP's shareholder history, click here.